AMY NEWSTROM: Open Payments
NPI 1194030007 · RAPID CITY, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$588 in 27 payments from 13 companies in 2025. Trend: 2023 $709 · 2024 $454 · 2025 $588
Food & beverage: $588
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $109 |
| Lundbeck LLC | 4 | $100 |
| Axsome Therapeutics, Inc. | 3 | $67 |
| HARMONY BIOSCIENCES LLC | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Collegium Pharmaceutical, Inc. | 2 | $41 |
| Supernus Pharmaceuticals, Inc. | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Alkermes, Inc. | 1 | $26 |
| ABBVIE INC. | 1 | $26 |
Products named: REXULTI, Auvelity, AUSTEDO XR, WAKIX, UZEDY, TRINTELLIX, Jornay PM, Qelbree.
Industry payments across SD — which companies pay providers there.
